Latin America BFS Technology Market 2017–2027
BFS technology (Blow fill technology), is a type of aseptic technique that is used for liquid packaging in containers. This technology is used as an excellent form of aseptic technology by regulatory bodies such as the U.S. Food and Drug Administration (FDA) in the packaging of pharmaceutical and medical devices. The main purpose of BFS technology is to sealed, form, and filled containers without the inference of humans. This technology is widely used to produce aseptically sterile pharmaceutical liquid products. Nowadays, the application of BFS technology has been also expanded into injectable and biologics, such as vaccines and monoclonal antibodies (mAbs). They are also used across food & beverages, cosmetics, and personal care. BFS technology reduces the chances of microbial contamination and penetration of foreign particles.
The Latin America BFS technology market is projected to reach around US$ 407.1 Million by the end of 2027, in terms of revenue, growing at CAGR of 6.6% during the forecast period (2019-2027).
Rising need to prevent the reuse of a medical product is one of the prime factors fueling the growth of the Latin America BFS technology market. Pharmaceutical products produced by using blow fill seal technology cannot be resealed again and therefore reduce the chances of counterfeit products. Hence, rising need to prevent the reuse of pharmaceutical products is projected to propel the growth of the Latin America BFS technology market.
Growing demand for pre-fillable syringes in the Latin America region is a major factor augmenting the market growth of blow fill seal technology. BFS technology eradicates the risk of contamination in the production of drug formulation because there is no human intervention. Therefore, this technology is highly preferred for producing pre-fillable syringes and this is projected to propel the growth of the Latin America BFS technology market.
On basis of the region, Brazil dominated the Latin America BFS technology market in 2018, accounting for 42.2% share in terms of value, followed by Mexico and Rest of Latin America.
Figure 1. Latin America BFS Technology Market, Revenue Share (%), By Country, 2018
In the course of the blow fill seal process, cutting and extrusion of plastic create a high level of non-viable particulates. This factor is expected to hinder the growth of the Latin America BFS technology market. This non-viable particulate leads to instability in the highly potent drugs. Hence, the generation of particulate during cutting &extrusion of plastic is projected to hamper the market growth.
A concern associated with the moisture and oxygen barriers as BFS technology utilizes plastic, low-density polyethylene, which has low moisture and oxygen barriers and the gases can easily enter into the primary packaging. This factor is expected to restrict market growth. The oxygen-sensitive products face a challenge of viability and require special secondary packaging.
The high cost of blow fill seal machines makes it difficult for small pharmaceutical companies to buy this advanced machine for the packaging of the product. For this, small scale manufacturers are leasing out of blow fill seal machines in Latin America and this is expected to present enormous opportunity in the blow fill seal technology market over the forecast timeframe.
Rising adoption of blow fill seal technology across the food &beverage industry for in-house packaging of a food product is projected to provide potential growth opportunities to the Latin America BFS technology market. Blow fill seal technology is gaining huge demand on the account of rising awareness regarding hygiene among the consumer as well as manufacturer and this is projected to fuel the market growth.
Figure 2. Latin America BFS Technology Market– Opportunity Analysis
The growing trend of integrating insertion technology in fill seal inserting technology which is done after blowing and filling drug. The incorporation of insertion with blow fill seal makes BFS technology more advanced and allows insertion of preservative-free multi-dose system or micro-brittle applicator as per the requirements. This trend of incorporating advanced technology in BFS will propel the growth of the Latin America BFS technology market.
The advent of co-extrusion technology for oxygen and carbon dioxide sensitive injectable drugs is a major trend that has been observed in the market. In the co-extrusion, the barrier material is tapped between the polypropylene and polyethylene layers, with an inner layer of LDPE and EVOH which avoid the penetration of oxygen through the parison. Thus the advent of co-extrusion technology is projected to fuel market growth.
Figure 3. Latin America BFS Technology Market, Revenue Share (%), By Product Type, in 2018
On the basis of product type, in 2018, others product type has accounted the largest market share of 71.6% in terms of value, followed by the ampoules and bottles.
Figure 4. Latin America BFS Technology Market – Value Chain Analysis
Key players operating in Latin America BFS technology market are Unither Pharmaceuticals, Takeda Pharmaceuticals International AG, Brevetti Angela S.R.L., Unipharma, LLC, Rommelag Kunststoff-Maschinen Vertriebsgesellschaft mbH, Horizon Pharmaceuticals, Inc., Weiler Engineering Inc., and Nephron Pharmaceuticals Corporation.
Few Recent Developments
Weiler Engineering Inc.
- The company exhibits its technology at various trade expos and showcased its Blow Fill Seal technology at Interphex